Stay updated on TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov page displays the completed Phase 1 TRK-250 study for idiopathic pulmonary fibrosis, with details about its design, participants, locations, and safety outcomes.SummaryDifference46%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer now shows site revision v3.8.0 instead of v3.7.2; the study page still displays a 403 error.SummaryDifference0.2%

- Check20 days agoChange DetectedA sitewide notice appears above the page, linking to updates and FAQs about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedAccess to the study record is now blocked by a 403 Forbidden page, replacing the full trial information. This change prevents users from viewing core details about the trial, including its design and locations.SummaryDifference17%

Stay in the know with updates to TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRK-250 in Idiopathic Pulmonary Fibrosis Clinical Trial page.